Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lowered its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 264,662 shares of the company’s stock after selling 3,602 shares during the quarter. Victory Capital Management Inc.’s holdings in Acadia Healthcare were worth $16,782,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Crossmark Global Holdings Inc. boosted its stake in Acadia Healthcare by 6.6% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 7,077 shares of the company’s stock worth $449,000 after purchasing an additional 440 shares during the last quarter. Covestor Ltd boosted its stake in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after purchasing an additional 1,018 shares during the last quarter. Atria Investments Inc boosted its stake in Acadia Healthcare by 4.7% during the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after purchasing an additional 308 shares during the last quarter. Assetmark Inc. boosted its stake in Acadia Healthcare by 66.1% during the 3rd quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock worth $94,000 after purchasing an additional 591 shares during the last quarter. Finally, Verdence Capital Advisors LLC boosted its stake in Acadia Healthcare by 32.8% during the 3rd quarter. Verdence Capital Advisors LLC now owns 4,664 shares of the company’s stock worth $296,000 after purchasing an additional 1,152 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on ACHC shares. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft lifted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Thursday, November 14th. Royal Bank of Canada reduced their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday. Finally, Barclays reduced their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $83.33.

Acadia Healthcare Stock Down 0.1 %

Acadia Healthcare stock opened at $37.09 on Wednesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market capitalization of $3.45 billion, a price-to-earnings ratio of 12.16, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The stock’s fifty day moving average is $56.48 and its two-hundred day moving average is $65.14.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 earnings per share. Analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.